Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation

Biological/cell based
General health
Online since 4 September 2025, updated 98 days ago

About this trial

This feasibility trial is enrolling 10 participants with chronic spinal cord injury to test the safety of intrathecal Wharton’s jelly mesenchymal stem cell (WJ-MSC) therapy combined with transcutaneous spinal stimulation (tSS). WJ-MSCs are stem cells derived from connective tissue found in the umbilical cord. tSS is a non-invasive technique that uses surface electrodes to deliver electrical stimulation aimed at modifying spinal cord function. If included, participants will receive 3 intrathecal doses of WJ-MSCs at 6-week intervals, combined with 18 weeks of tSS and neurorehabilitation sessions. Final testing of safety and feasibility will be performed after 2 years.

Included participants

Gender
All
Age
16 - 70 years
Injury level
C1 - T12
  • Severity (AIS)?
  • AIS-A
    AIS-B
    AIS-C
    Time since injury
    1 year - 5 years
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    C1-T12

    What’s involved

    Type

    Biological/cell based

    Details

    - Participants will receive 3 intrathecal doses of Wharton’s jelly mesenchymal stem cell (WJ-MSC) at 6-week intervals, combined with 18 weeks of transcutaneous spinal stimulation (tSS) assisted neurorehabilitation. - WJ-MSCs are stem cells derived from connective tissue found in the umbilical cord. - tSS is a non-invasive technique that uses surface electrodes to deliver electrical stimulation aimed at modifying spinal cord function. - Final testing of safety and feasibility will be performed after 2 years.

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Arm/hand function

    Sensory function

    Standing/walking/mobility

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more


    • Trial recruitment status
    • Recruiting soon
    • Trial start date
    • 1 Sep 2025
    • Organisation
    • Institut Guttmann
    • Trial recruitment status
    • Recruiting soon
    • Trial start date
    • 1 Sep 2025
    • Organisation
    • Institut Guttmann

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more